NF-κB

LTβR-IN-1 is a potent, selective lymphotoxin β receptor (LTβR) inhibitor with an IC50 of 10 μM.

Edasalonexent (CAT-1004) is an orally bioavailable NF-κB inhibitor.

DHMEQ racemate is a NF-κB inhibitor. DHMEQ racemate is less active than (-)-DHMEQ.